Walpurgis K - Search Results

1

Chromatographic-mass spectrometric analysis of peptidic analytes (2-10 kDa) in doping control urine samples.

Thomas A, Walpurgis K, Thevis M. Thomas A, et al. Among authors: walpurgis k. J Mass Spectrom. 2024 Jan;59(1):e4996. doi: 10.1002/jms.4996. J Mass Spectrom. 2024. PMID: 38197510

2

Analysis of Potential Gene Doping Preparations for Transgenic DNA in the Context of Sports Drug Testing Programs.

Naumann N, Paßreiter A, Thomas A, Krug O, Walpurgis K, Thevis M. Naumann N, et al. Among authors: walpurgis k. Int J Mol Sci. 2023 Oct 31;24(21):15835. doi: 10.3390/ijms242115835. Int J Mol Sci. 2023. PMID: 37958821 Free PMC article.

3

Detection of doping control sample substitutions via single nucleotide polymorphism-based ID typing.

Naumann N, Walpurgis K, Rubio A, Thomas A, Paßreiter A, Thevis M. Naumann N, et al. Among authors: walpurgis k. Drug Test Anal. 2023 Nov-Dec;15(11-12):1521-1533. doi: 10.1002/dta.3597. Epub 2023 Nov 9. Drug Test Anal. 2023. PMID: 37946680

4

Detection of extracellular hemoglobin from Arenicola marina in doping control serum samples by means of liquid chromatography and high-resolution tandem mass spectrometry.

Walpurgis K, Gäde A, Thomas A, Gochard S, Delahaut P, Thevis M. Walpurgis K, et al. Drug Test Anal. 2023 Nov-Dec;15(11-12):1430-1438. doi: 10.1002/dta.3591. Epub 2023 Nov 2. Drug Test Anal. 2023. PMID: 37918029

5

Insulin-mimetic peptides in sports drug testing.

Thomas A, Krombholz S, Breuer J, Walpurgis K, Thevis M. Thomas A, et al. Among authors: walpurgis k. Drug Test Anal. 2023 Nov-Dec;15(11-12):1468-1476. doi: 10.1002/dta.3572. Epub 2023 Sep 11. Drug Test Anal. 2023. PMID: 37691519

6

Detection of capromorelin in urine following oral and dermal routes of administration.

Sobolevsky T, Walpurgis K, Goergens C, Fedoruk M, Lewis L, Ahrens B, Thevis M. Sobolevsky T, et al. Among authors: walpurgis k. Drug Test Anal. 2023 Nov-Dec;15(11-12):1449-1453. doi: 10.1002/dta.3573. Epub 2023 Sep 8. Drug Test Anal. 2023. PMID: 37688359

7

Myostatin inhibitory peptides in sports drug testing.

Walpurgis K, Agricola J, Thomas A, Thevis M. Walpurgis K, et al. Drug Test Anal. 2023 Nov-Dec;15(11-12):1477-1487. doi: 10.1002/dta.3473. Epub 2023 Mar 29. Drug Test Anal. 2023. PMID: 36946003

8

DropWise: current role and future perspectives of dried blood spots (DBS), blood microsampling, and their analysis in sports drug testing.

Thevis M, Walpurgis K, Thomas A. Thevis M, et al. Among authors: walpurgis k. Crit Rev Clin Lab Sci. 2023 Jan;60(1):41-62. doi: 10.1080/10408363.2022.2103085. Epub 2022 Aug 7. Crit Rev Clin Lab Sci. 2023. PMID: 35938300

9

Androgens, sports, and detection strategies for anabolic drug use.

Walpurgis K, Piper T, Thevis M. Walpurgis K, et al. Best Pract Res Clin Endocrinol Metab. 2022 Jul;36(4):101609. doi: 10.1016/j.beem.2021.101609. Epub 2021 Dec 27. Best Pract Res Clin Endocrinol Metab. 2022. PMID: 35120801 Review.

10

Detection of follistatin-based inhibitors of the TGF-β signaling pathways in serum/plasma by means of LC-HRMS/MS and Western blotting.

Walpurgis K, Weigand T, Knoop A, Thomas A, Reichel C, Dellanna F, Thevis M. Walpurgis K, et al. Drug Test Anal. 2020 Nov;12(11-12):1636-1648. doi: 10.1002/dta.2925. Epub 2020 Oct 12. Drug Test Anal. 2020. PMID: 32959984

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

47 results

Search Page